Abstract Raman microspectroscopy is a non-invasive, in vitro analytical tool which is being increasingly explored for its potential in clinical applications and monitoring the uptake, mechanism of action and cellular interaction at a molecular level of chemotherapeutic drugs, ultimately as a potential label-free preclinical screening and companion diagnostic tool. In this study, doxorubicin (DOX), a Bgold standardĉ hemotherapeutic drug, is employed as a model in the in vitro lung cancer cell line A549 in order to demonstrate the potential of Raman microspectroscopy to screen and identify spectroscopic markers of its trafficking and mechanism of action. Confocal laser scanning microscopy (CLSM) was used in parallel to illustrate the uptake and subcellular localisation, and cytotoxicity assays were employed to establish the toxicity profiles for early and late exposure times of A549 to DOX. Multivariate statistical analysis, consisting of principal components analysis (PCA), partial least squares regression (PLSR) and independent component analysis (ICA), was used to elucidate the spectroscopic signatures associated with DOX uptake and subcellular interaction. Raman spectroscopic profiling illustrates both drug kinetics and its pharmacodynamics in the cell and associated biochemical changes, demonstrating that DOX is mainly localised in the nuclear area, saturating the nucleolus first, within~6 h of exposure, before the surrounding nuclear areas after~12 h, and only accumulates in the cytoplasm after 48 h. PLSR over varying time intervals enables identification of DOX-DNA binding at early stages of exposure (0-12 h), while regression over longer time periods (24-72 h) reveals spectroscopic signatures associated with the metabolic cellular response.
Introduction
Doxorubicin (DOX), a cell cycle non-specific chemotherapeutic agent, is one of the two first anthracycline antibiotics isolated from Streptomyces peucetius [1] and among the most widely used chemotherapeutic agents, despite its numerous side effects [2, 3] , and is highly effective in treating different types of cancers, from leukaemia, thyroid, and lung to many other neoplasia, especially metastatic and invasive ones [3] [4] [5] [6] . The accepted mechanisms of action of DOX are complex, not fully understood and include the interaction (i) with the cellular nuclear area, consisting of DNA intercalation, crosslinking, binding and alkylation, inhibition of topoisomerase I and II and RNA polymerase, all inducing DNA damage, inhibition of DNA replication and protein synthesis (rRNA transcription inhibition), as a consequence, leading to nucleolar disruption and cellular apoptosis [7] and (ii) with the cell membrane and mitochondria, resulting in generation of reactive oxygen species leading to direct membrane damage and oxidative stress, responsible for the major DOX side effect, cardiomyopathy [3, [8] [9] [10] . DNA remains the main target of cancer therapeutics, whereby induction of DNA damage initiates a cascade of events that determines cellular apoptosis. DNA damage level and repair, by expression of anti-apoptotic proteins such as bcl-2 and resistance to apoptosis, are the main processes involved in carcinogenesis and in the response of cancer cells to cancer chemotherapy [11, 12] .
Apoptosis, known as programmed cell death, plays an important role in the internal environmental homeostasis and is closely associated with the development of cancer and in chemotherapy, by implication, of drug-induced cell apoptosis [13] . One of the pathways leading to apoptosis disruption and tumour development is the nucleolar stress pathway [14] . In fact, the nucleolus, known also as a ribosome factory, is the most prominent structure inside the nucleus, acting as a central integration of signalling pathways and performing numerous functions such as production of ribosome subunits, RNA editing and cell cycle and playing an important role in cancer development by dysregulation of its functions [15] [16] [17] . Owing to its fundamental contribution in cancer proliferation, the nucleolus is the target for chemotherapeutic drugs such as actinomycin D, which inhibits rRNA synthesis; cisplatin which interferes with RNA polymerase I in the nucleolus, decreasing rDNA transcription; 5-fluoruracil, which targets rRNA processing, DNA/RNA synthesis and DNA repair and DOX, which is known to disrupt nucleolar morphology and decrease rDNA transcription [14, 18] . It has also been shown in previous Raman spectroscopic studies that this subnuclear region is responsible for the discrimination between cancer cell lines [19] .
Lung cancer, which is among the most common cancers worldwide, is by far the highest cause of cancer-related death and has a 5-year survival of 15 %. The main treatments of lung cancer are chemotherapy and radiotherapy, but these approaches have serious side effects and drug resistance is often developed during treatment [20] . Thus, a better understanding of the mechanism of drug action and the cellular responses at the preclinical stage is crucial to improve patient survival. To this end, Raman microspectroscopy, a non-invasive, powerful, label-free, in vitro screening tool, is presented as the ideal candidate owing to its ability to detect chemical, biological and physical changes of biomolecules at subcellular level and provide a molecular fingerprint of the sample of interest, in this case cancer cell physiology, at a subcellular level, during chemotherapeutic treatment [21] [22] [23] [24] .
Raman microspectroscopy has attracted considerable attention in recent years for applications in areas such as the drug discovery process, quality control during industrial manufacturing and detection of counterfeit products in the pharmaceutical industry [23, 25, 26] . Biomedical and clinical applications have also been explored extensively [27, 28] and its potential as a screening technique either for normal/cancer cell discrimination or in chemotherapeutic and cellular process screening has been demonstrated [19, 29] . Therefore, it can be developed as a companion diagnostic tool, providing details about drug efficacy and safety, as detailed in the US Food and Drug Administration (FDA) guidance document issued in August 2014, which defines such a tool as an in vitro diagnostic device that provides information that is essential for the safety and efficacy of a corresponding therapeutic product [30, 31] . The demonstration of Raman microspectroscopy as a companion diagnostic for screening and analysis of commercial chemotherapeutic agents could be of significant importance in cancer research and especially in preclinical in vitro screening, a concept introduced by the US National Cancer Institute (NCI) in 1955 and providing screening models and support to research, as a model which accurately predicts drug efficacy at a molecular level, clinical activity and pharmacodynamics and kinetics [32, 33] .
Previously, DOX, routinely used for lung cancer therapy, was employed with A549, a non-small lung cancer cell line, and Raman analysis of the distribution of the drug in the cell and the changes in the cellular spectroscopic signatures was performed at a fixed point in time (24 h) [29] .
In the present paper, investigations were extended to look at the evolution of the responses in order to track the drug reactions for early and late stage exposure, globally understand the mechanism of action and monitor the subsequent cellular behaviour using Raman microspectroscopy. The study demonstrates the potential of Raman spectroscopy to monitor the drug uptake and the cellular responses at a subcellular level, but also to elucidate details of the pharmacodynamics and drug cellular kinetics of the clinically prescribed drug.
Materials and methods

Materials
A549 human lung adenocarcinoma cells with the alveolar type II phenotype were obtained from ATCC (Manassas, VA, USA). Doxorubicin hydrochloride® powder (Sigma Life Sciences, Ireland) was diluted in 1 mL sterile water to the required concentration (17.25 mM).
Alamar blue (AB) (10× ready to use solution) and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) were obtained from Sigma Aldrich, Ireland. For cytotoxicity assays, an AB/MTT solution, 1.5 mL of AB and 3 mL of MTT stock solution (2.5 mg/mL, 25 mg MTT/10 mL PBS) in 30 mL of fresh medium was prepared prior to the tests.
Cell culture
A549 cells were cultured in DMEM (with 2 mM L-glutamine) with 10 % foetal bovine serum (FBS) at 37°C in a humidified atmosphere containing 5 % CO 2 and cells were split every 2 days to maintain~60 % confluence.
For confocal laser scanning fluorescence microscopy (CLSM) and Raman microspectroscopic analysis, cell number was determined using a Beckman Coulter Particle Count and Size Analysis® Z2Cell Counter. AB and MTT assays were both measured with a Cytotox SpectraMax®M3 plate reader using Soft Max® Pro6.2.2 software. After incubation in DOX, plates were washed with PBS and 100 μL of AB/MTT solution was added to each well. Plates were then incubated for 3 h and AB fluorescence was measured first in the plate reader using 540 nm excitation and 595 nm emission, then the medium was removed, the plates were washed with PBS and 100 μL of DMSO (dimethyl sulfoxide) was added to each well. MTT absorbance was read at 570 nm.
All cytotoxicity assays were made in triplicate and repeated three times, and viability data was fitted by a four-parameter Hill equation analysis using SigmaPlot 10.0 to yield values of the mean inhibitory concentration, IC 50 .
Confocal laser scanning fluorescence microscopy
Approximately 1 × 10 4 cells were allowed to attach on uncoated glass-bottom Petri dishes (MatTek Corporation, USA) for 2 h, after which they were covered with cell culture medium. After 24 h incubation, the medium was removed and samples were rinsed twice with sterile PBS, new fresh medium containing DOX corresponding to the inhibitory concentration, IC 50 , determined by cytotoxicity assays for each time point (48 and 72 h) and adjusted to the cell number ( 50 dose was initially chosen, on the basis of previous studies, in order to monitor the kinetics of the uptake of DOX at earlier times. This dose was reduced at longer times, as it would be too toxic at the longer exposure periods. After each incubation period (2, 6, 12, 24, 48 and 72 h), cells were washed twice with sterile PBS and fixed in formalin (4 %, 15 min).
A Horiba Jobin-Yvon LabRAM HR800 spectrometer with a 785-nm, 300-mW diode laser as source (~100 mW at the sample), Peltier cooled 16-bit CCD, 300 lines/mm grating and 100 μM confocal hole was used for this work. Spectra were acquired in the range from 400 cm -1 to 1800 cm -1 using a × 100 objective (LCPlanN, Olympus), in dry conditions, for 30 s twice, from three cell locations (cytoplasm, nucleus and nucleolus) to finally produce a data set of 30 points per cell location for each time point, 2, 6, 12, 24, 48 and 72 h after DOX exposure and for control cells, over a total of 210 cells corresponding to a total data set of 630 spectra.
Data analysis
Raman spectral preprocessing and analysis were performed in Matlab 2013 using algorithms developed in-house. Prior to analysis, background was subtracted using an NCLS (nonnegatively constrained least squares) algorithm and spectra were subsequently smoothed (Savitzky-Golay filter 3th order, 11 points), baseline corrected (fifth-order polynomial) and vector normalised.
Principal components analysis (PCA) was employed as an unsupervised multivariate approach to analyse data and the effects of doxorubicin in each cell localisation. The order of the PCs denotes their importance to the dataset and PC1 describes the highest amount of variation [34] . Partial least squares regression (PLSR) was employed to track the temporal and dose-dependent evolution of the spectral signatures in the subcellular regions. PLSR is a statistical regression technique which reduces the dimensionality of the data and correlates information in an X data set matrix to the matrix of a Y data according to the equation Y = XB + E, where B is a matrix of regression coefficients and E is the regression residual. In this work, the X matrix is represented by the Raman spectra and the Y matrix consists of values of the DOX concentration inside the cells and the time evolution [35] [36] [37] .
The percentage of variance explained in the response variable (Y) as a function of the number of components was calculated using 10-fold cross-validation and from a plot of the percentage of variance explained as a function of number of components, the majority percentage of variance (above 90 %) was found to be explained by the first three components.
The regression coefficients obtained by PLSR of Raman data regressed separately against DOX cellular concentration and time evolution were plotted and analysed. As a function of frequency, the coefficients illustrate the spectral features which are influenced by the intracellular interaction of the DOX and the resulting metabolic changes.
Independent component analysis (ICA), a signalprocessing technique, was also employed as an extension to PCA. ICA is an unsupervised statistical technique able to identify latent and statistically independent variables called independent components, which correspond to the pure signal underlying the observed signal, and to interpret their different contributions. In the case of Raman microspectroscopy, ICA can be used to identify and extract principal spectral contributions such as those from substrate, using the same number of ICs (independent components) as PCs, which is three components, which can then be removed or studied in their own right [12, [38] [39] [40] . The first independent component (IC1) explains the highest percentage of variance and was used to further examine the temporal evolution of the spectral signatures.
Results
Cytotoxicity assays
The cytotoxicity of A549 cells to DOX exposure using both the AB and MTT assays for 24 h has been previously reported [29] , indicating an IC 50 of 0.42 ± 0.06 μM and 0.55 ± 0.16 μM for AB and MTT, respectively. Figure S1 of the Electronic Supplementary Material (ESM) shows the dose-dependent cytotoxicity of DOX after 48 h (ESM Fig. S1a ) and 72 h (ESM Fig. S1b ) exposure, for the A549 cell line, according to the AB and MTT in vitro cytotoxicity assays. Viability is expressed as percentage compared to control (non-exposed healthy cells), and the error bars indicate the standard deviation of six independent replicate measurements. For both in vitro assays and for all times of exposure, a partial loss of cell population viability is observed.
The AB and MTT assays for the A549 cell line show similar responses for long time exposure (48 and 72 h) but slightly different ones for 24 h. However, the IC 50 values for 48 h exposure for A549 cells are comparable and were determined to be 0.30 ± 0.04 μM and 0.31 ± 0.05 μM for AB and MTT, respectively. Similar behaviour was found after 72 h treatment, characterised by IC 50 values of 0.29 ± 0.02 μM and 0.27 ± 0.02 μM, respectively, for AB and MTT.
The MTT assay is a reflection of mitochondrial activity while the AB assay is the expression of general cellular metabolism. The somewhat greater sensitivity of MTT compared to AB at the early stages is consistent with a mechanism of interaction which induces early apoptosis [41, 42] . Nevertheless, since the mechanisms and cellular effects for the long time exposures of 48 and 72 h will be compared to those for shorter exposures 0-24 h, the IC 50 determined by the MTT assay was used throughout the study for comparability purposes and Fig. 1 shows the dose-dependent cytotoxicity for those time points.
For Raman microspectroscopy and confocal laser scanning fluorescence microscopy, the DOX dose used was scaled to cell numbers, according to a linear relationship between MTT response and cell number, using each corresponding IC 50 and Table 1 shows the different concentrations used [43] [44] [45] .
Confocal laser scanning fluorescence microscopy
Confocal laser scanning fluorescence microscopy (CLSM) was employed to visualise and confirm the DOX intracellular internalisation and subcellular localisation. Figure 2 illustrates the images for different DOX exposure times, from 2 h to 72 h, clearly demonstrating that DOX is predominantly accumulated in the nuclear region at all time points. The DOX nuclear accumulation is obvious even after only 2 h, Fig. 1 MTT in vitro dose-dependent cytotoxicity assays of DOX toward A549 cell line for short (0-24 h) and long exposure times (48 h, 72 h). Viability is expressed as % compared to control, and the error bars indicate the standard deviation of six independent replicate measurements suggesting that this commercial drug is trafficked straight to the nuclear area without any accumulation in the cytoplasm up to 24 h. Some trace amounts do appear in the cytoplasm at 48 and 72 h, consistent with the onset of a late cytoplasmic DOX mechanism of action associated with oxidative stress as a result of reactive oxygen species production [12] . Compared to healthy control cells, exposed cells appear smaller in size and round or oval in shape and exhibit noticeable fragmentation of nucleoli within the nucleus, with tightly packed cytoplasm and membrane blebbing. All these morphological changes confirm that cells are undergoing apoptosis [16, 18, 29, 46] .
Raman microspectroscopy
Raman microspectrosopy has previously been demonstrated to be capable of tracking DOX inside the cellular compartments and differentiating between its different mechanisms of action and the cellular responses due to drug treatment at a fixed time point of 24 h exposure. In order to further investigate the subcellular responses and to track the drug pathway, Raman profiles from the three subcellular compartments (nucleolus, nucleus and cytoplasm) were analysed at shorter timescales of 2, 6 and 12 h at the 24 h IC 50 concentration, and at the longer exposure times of 48 h and 72 h, at the IC 50 concentration, adjusted to the cell number, of these time points, as determined using the MTT assay (Fig. 1, Table 1 ). Figure 3 shows the mean spectra for each time point of the three cellular localisations, namely the nucleus, the primary location of DNA, the nucleolus, a subcompartment of the nucleus, which contains RNA and small amount of DNA, and the surrounding cytoplasm containing the cytoskeleton, a framework of protein filaments, all protected by the plasma membrane [47, 48] .
In general, nucleic acids can be identified by peaks characteristic of nucleotide and sugar-phosphate backbone vibrations [24] and the main bands are for example at 785 cm . Lipids are predominatly represented by peaks at 700-720 cm -1 , related to C-C-N + symmetric stretching in phosphatidylcholine, 1303 cm -1 assigned to C-H vibration and between 1410 and 1495 cm -1 corresponding to C-H deformation [24, 29, 49] . Since the Raman spectra are characteristic of the molecular structure, any changes to that structure, for example after chemotherapeutic treatment, can be detected and monitored.
As an illustration, for both nucleolar and nuclear regions (Fig. 3b, c) , an obvious shift towards lower wavenumbers of the band at 1095 cm -1 confirms again that DOX is able to bind to DNA externally, starting from the early stages of exposure [29] , and a decrease of the band at 785 cm -1 indicates a progressive DNA/RNA denaturation, while in the nuclear region, there is a decrease in the features at 830 cm -1 and, in the nucleolar area, an almost complete disappearance of the band at 813 cm -1 , potentially owing to cessation of DNA replication as a consequence of DNA denaturation and fragmentation [50, 51] . In the cytoplasmic area (Fig. 3d) , a slight increase in features at 1065 and 1080 cm -1 is observed, corresponding to protein C-N stretching, which may correspond to an increase of signaling proteins in cells going under apoptosis. 
It is notable that, for all cellular regions and over the time course, there is an increase in the principal DOX features (Fig. 3a, indicated by the highlighted regions in Fig. 3b-d ) at 440 and 465 cm , related to C-O-H and C-O. Notice, however, that DOX features only appear in the cytoplasm starting from 48 h exposure. Similar observations were found in CLSM images (Fig. 2) , confirming the primary localisation of DOX in the combined nuclear area for all time points before 48 h treatment.
In order to examine further the DOX cellular pathway, PCA of exposed cells versus control was employed and a clear separation occured according to PC1 for all time points compared to control, as previously demonstrated for 24 h exposure [29] (data not shown). The evolution of DOX peak intensities at 440, 465, 1215 and 1245 cm -1 , corresponding respectively to C-C-O, C-O, C-O-H and C-O vibrations of the DOX molecule, in the loading of PC1 was analysed, as shown in Fig. 4 . The intensity is expressed as a percentage of the highest value of each respective band in the three subcellular regions.
It is obvious that there is a progressive increase of DOX intracellular concentration until a plateau is reached after 6-12 h exposure and DOX is seen to accumulate in the nucleolus first, then the nucleus and after 48 h it appears in the cytoplasm. Since the bands at 1215 and 1245 cm -1 can be influenced by the proximity of protein features, further analysis was focused on the two bands at 440 and 465 cm -1 . Notably, according to these two DOX Raman bands, there is more DOX in the nucleolus than the nucleus for 2, 6 and 12 h exposure, with a maximum at 6 h. These observations are consistent with a mechanism of DOX being trafficked straight to the combined nuclear area, after a passive diffusion to the cells owing to its high lipophilicity, where it binds to the proteasome then translocates into the nuclear area, via nuclear pores, where it dissociates from the proteasome complex and binds to DNA with high affinity [1, 7] , a larger amount accumulating in the denser nucleolar area, which saturates more rapidly. Accumulation in the cytoplasm is only evident after 48 h, confirming previous studies showing that the intracellular DOX is primarily accumulated in the nuclear area, at short exposure times, and that the main mechanism of action is one of DNA intercalation, interfering with both DNA and RNA polymerase and inducing in consequence DNA replication and RNA transcription blockage [7, 52] . The observed plateau in the nuclear and nucleolar regions is more notable, given that the doses for 48 and 72 h were increased to the respective doses of 77.5 μM and 135 μM, respectively, compared to 13.75 μM for 24 h (Table 1) . Nevertheless, it is clear that the DOX concentration inside the combined nuclear regions becomes approximately constant after~24 h exposure, after In order to track the cellular changes associated with the progressive uptake of DOX in the subcellular regions, PLSR was employed, and spectra were regressed against time, progressively increasing the time interval from 0-6 to 0-72 h. The resultant regression coefficients for the nucleolar and nuclear region are shown in Fig. 5 .
In the case of the regression as a function of time for the nuclear region (Fig. 5b) , the coefficients over the period 0-6 h and 0-12 h are almost identical, whereas regression beyond this period results in significant changes to the regression coefficients. In the case of the nucleolar spectral data (Fig. 5a) , such significant changes in the regression coefficients are evident on progressing from 0-6 h to 0-12 h, and beyond. For both cellular regions, the time points after which the regression coefficients begin to change significantly coincide with those of the onset of saturation of the DOX-related spectral features in Fig. 4 , indicating that the regression over the time points up to saturation identifies spectral features associated with the initial drug mechanism of action, before saturation, after which the cellular responses become evident.
In the T:0-6 h regression coefficients for the nucleolar region (Fig. 5b) , indicating lipid denaturation, probably of the surronding cytoplasmic membrane and features at 1005 cm -1 (phenylalanine), 1607 cm -1 (tyrosine and phenylalanine ring vibration C = C) and 1673 cm -1 (amide I), indicating a change in nucleolar proteins [21, 24, 29, 49, 51, 56, 57] .
Over the regression period T:0-12 h, although the overall profile of the coefficients is distinct compared to that of the nucleolar region, similar spectral changes are observed for the nuclear region, in addition to those at 830 cm -1 (O-P-O asymmetric stretching, DNA B form), 881 cm -1 (deoxyribose ring breathing) and 1340 cm -1 (adenine and guanine). The nucleolar and nuclear regions are composed of similar biochemical constituents, and similar changes to these are prominent in the regression coefficients of both regions. However, the distinctly different profiles in Fig. 5a (nucleolus T:0-6 h) and Fig. 5b (nucleus 0-12 h) indicate different rates and degrees of interactions with the constituent conponents in the different subcellular regions.
Notably, as shown in Fig. S2 (see ESM), for each cellular region, the coefficients for regression against the internalised dose, as determined by the peak intensity in the loading 1 of PCA control versus exposed cells (Fig. 4) , are largely invariable, and almost identical to the time-dependent regression coefficient profile (T:0-6 h for nucleolus and T:0-12 h for nucleus) (Fig. 5) up to the saturation point (Fig. 4) So, for both nucleus and nucleolus and for both regression against short time exposure and DOX cellular concentration, a notable decrease in DNA and RNA features for example at 728, 785-795, 813, 1376 and 1486 cm -1 is evident. However, the changes to the nucleic acid features over this initial period are much more pronounced and more rapid in the nucleolar region than in the nucleus itself.
Following the initial DOX binding interactions in the nucleoli and then nuclear regions of the cell, and although the DOX concentrations saturate in the nuclear regions after (Fig. 5) , the cellular features continue to evolve as a function of time, in response to the action of the drug. This can be clearly seen in Fig. 5 , but, in order to differentiate the spectral characteristics of the initial chemical interactions of the drug from the subsequent cellular responses, the spectral evolution over the time period 24-72 h was regressed against time and internalised cellular DOX concentration. Notably, in the PLSR analysis of nucleolus and nucleus regressed against time over the later stages, shown in Fig. 6 (IA and IIA) , only cellular features appear and no DOX features are apparent, which confirms the fact that after a certain time, DOX reaches a constant concentration inside the nuclear regions of the cells, as evidenced by the plateau in Fig. 4 .
As seen in Fig. 6I , for the nucleolar regions at late stages (24, 48 and 72 h), there is an increase in protein features at 447, 454, 1005 cm -1 (phenylalanine), 853 cm -1 (tyrosine ring breathing), 1207 cm -1 (phenylalanine, tryptophan and tyrosine), 1230 cm -1 (amide III) and 1660 cm -1 (amide I), consistent with an afflux of anti-apoptotic protein trying to repair DNA and avoid apoptosis [12] . There is also a significant decrease in DNA features at 785 cm -1 (cytosine and thymine), 830 cm -1 (DNA B form), 1220 cm -1 (adenine and thymine) and 1577 cm -1 (adenine and guanine), representative of DNA depletion and denaturation due to long-term effects of DOX.
Similar increases in protein features as a function of time in the later stages of exposure are apparent in the nuclear area, as shown in Fig. 6II , in addition to a progressive decrease in DNA features at 785, 795 cm -1 (cytosine and thymine), 1095 cm -1 (DNA backbone O-P-O symmetric stretching), 1220 cm -1 (adenine and thymine), 1376 cm -1 (thymine), 1577 cm -1 (adenine and guanine) and a lipid denaturation indicated by peaks at 700, 715, 720, 1127, 1450 and 1491 cm -1 . In both nucleolar and nuclear regions at prolonged exposures, a notable increase is observed in features at 1047 cm -1 (RNA P-O stretching, sugar phosphate -C-O-stretching) and 1270 cm -1 (RNA uracil and cytosine ring stretching), while that at 1376 cm -1 (thymine) is seen to decrease. The continued changes to RNA features in both nucleolus and nucleus over the later time period could be explained by a decrease of RNA as a consequence of DNA denaturation and blockage of its replication but the concomitant increase in some RNA peaks could be due to nucleolar fragmentation, resulting in RNA spread into the nucleus [16, 58] .
In addition to spectral features which may be characteristic of DNA and RNA depletion and nucleolar fragmentation, there is an increase in both lipid and protein features, at 645 cm , as a cellular response to DOX exposure, which may be associated with the efflux of anti-apoptotic protein and a synthesis of lipidic vesicules as a way to remove DOX to the extracellular environment [29, 56, 59, 60] .
The increase in phenylalanine in both nucleolar and nuclear regions seems to be a marker of the late apoptosis stage, at which point nucleolar fragmentation is complete, leaving an empty space with only cellular membrane (Fig. 6) [57, 61] .
Thus, it appears that regression against DOX cellular concentration shows the initial DOX accumulation inside the cells, its nuclear binding and its subsequent effects, including DNA damage, while regression against varying time intervals can elucidate and differentiate both the initial DOX mechanism of action and its cellular effects, such as depletion in DNA, RNA and proteins leading to apoptosis and the cells' reactions to those DOX effects which could be a marker of any cellular drug resistance. Figure 7 shows the PLSR of the cytoplasmic region of the cell against time and DOX cellular concentration. In both regression coefficient profiles, there are obvious DOX features at 440-465 cm -1 and 1215-1245 cm -1 , in addition to cellular ones related to proteins and lipids, for example at 524 cm -1 , corresponding to phosphatidylserine externalization as an indicator of cell signalling in apoptosis [62, 63] , 538 cm -1 related to cholesterol ester, which increases owing to alteration of the function of integral endoplasmic reticulum membrane proteins and is a marker of apoptosis [64, 65] conformational forms indicating a protein denaturation) [56, 59] . Features at 645-1005 cm -1 (C-C phenylalanine) and 1030 cm -1 (C-H phenylalanine) indicate a change in the protein environment as a result of DOX exposure [50] , while changes in the profile of the band at 1450 cm -1 (C-H deformation) and around 1303 cm -1 (lipid C-H vibration) [59] are consistent with a lipid structure denaturation by peroxidation due to ROS production under DOX treatment [13] .
Discussion
Raman spectroscopic microscopy can clearly track the kinetics of the uptake and accumulation of the chemotherapeutic drug DOX at a subcellular level in vitro, and can differentiate the biochemical responses associated with the subcellular regions of nucleolus, nucleus and cytoplasm, both in terms of the mechanisms of action and the subsequent cellular metabolic responses. In both cases, the spectroscopic signatures are a complex combination of the contibutions of the many biomolecular responses, and their evolution requires the use of multivariate regression analysis. Independent components analysis can be used to extract the primary contributions of this combinatorial response, at each time point, as shown in Fig. S3 (see ESM) , for each exposure time point for nucleolar and nuclear regions of the cell, again highlighting the multivariate nature of the spectral responses.
The evolution of selected features can be plotted against time and correlated with that of the uptake and accumulation of the DOX in the different subcellular regions, as well as each other, as shown in Fig. 8 . The intensities of DNA, RNA, protein and lipid bands was determined by ICA after DOX ) Raman bands as a function of time for the A549 cell line for each nuclear cellular compartment, (i) nucleolus and (ii) nucleus. Intensities are expressed in percentage according to the maximum value for each nuclear area and standard deviation corresponds to the spectra variations for each band subtraction, as ICA can identify contributions of spectral cellular components independently while the DOX band was determined by PCA control vs exposed cells (Fig. 4) .
The interaction with DNA and RNA in both the nucleolar and nuclear regions of the cell as a function of time is apparent in Fig. 8a, showing (RNA cytosine and adenine ring stretching). Notably, the feature at 785 cm -1 (cytosine and thymine, DNA backbone O-P-O stretching) can be ascribed to either DNA or RNA.
The changes in the nucleic acid bands in the nucleolar region are concomitant with the accumulation of DOX, and the changes cease when the accumulation of DOX saturates, associating these with an instantaneous interaction with the biochemical components, and therefore the initial DOX-DNA binding [66, 67] . In the nucleus, the equivalent changes occur more slowly, but also appear to saturate once the accumulation of DOX in the nucleus has saturated. A further observation is that the relative changes in the nucleic acid spectral features are much stronger in the nucleolus than in the nuclear region. Moreover, the same kinetics of evolution were found using PLSR, highlighting that the same cellular features, mainly DNA and RNA, are affected by DOX in both nucleolus and nucleus owing to interuption of DNA replication and RNA transcription, but at different rates and intervals. DOX affects the nucleolus instantaneously, and once saturation of DOX is reached at 6 h, an almost total reduction of DNA and RNA features to~20 % has occured. In the case of the nucleus, this decrease is slower even after saturation at 12 h and reaches only~40 % of the initial levels.
It is also obvious that, after DOX exposure, proteins and lipids (Fig. 8b ) start decreasing as a consequence of RNA/ DNA alteration, and then increase at later stages of the cellular responses, which corresponds to an increase of anti-apoptotic proteins and a synthesis of lipid vesicules as a cellular reaction to the chemotherapeutic treatment, after which cells initiate late apoptosis corresponding to a point of no return.
Previous studies have investigated the DOX nuclear accumulation by using either DOX fluorescence or indirect labeling techniques, showing an intimate relationship between DOX nuclear accumulation and its cellular concentration [68] . However, those approaches present some limitations, as DOX fluorescence can be influenced when it intercalates with DNA and the mechanisms of action of dyes used to probe DNA content [55] , for example, are unclear and can interfere with the process itself [69, 70] . No relationship between nuclear DOX accumulation and its cellular effects has been clearly defined. In contrast, using Raman microspectroscopy as an in vitro label-free tool to investigate drug kinetics and pharmacodynamics, coupled with multivariate data analysis, shows the DOX cellular distribution, interactions and effects.
It appears that the early stage responses are dominated by the kinetics of the chemotherapeutic drug accumulation, principally in the nucleolar region, and by the DOX-DNA interaction. Notably, the observed changes in these early stages are predominantly associated with RNA, rather than DNA, changes to which become more prominent in the interactions in the nuclear region. At later stages, when the localised DOX concentration has reached the saturation point, the cellular response to DOX treatment becomes prominent. Saturation of the nucleolar region prior to the nuclear highlights again the importance of this subcellular region, not only in the cancer process but also in chemotherapy and cellular resistance, since it is the first to be targetted by DOX and as a consequence the first to react to drug exposure, followed by the nucleus and finally by the cytoplasm after 48 h exposure. The observation that appreciable accumulation of DOX in the cytoplasm is only apparent after such prolonged exposure times may have implications for the relative contributions of alternative routes towards cell death based on oxidative stress in the cytoplasm [71] .
Conclusion
The US FDA classifies DOX as one of the most effective chemotherapeutic drugs used worldwide for the treatment of various cancers [1, 7] . Nevertheless, it presents serious clinical side effects and its full mechanism of action is still not completely understood. The development of an in vitro screening method to detect drugs inside cells and map their mechanism of action and the cellular response is therefore of critical importance.
In the present work, Raman microspectroscopy associated with multivariate data analysis (PCA, PLSR and ICA) has been demonstrated to be capable of not only monitoring the subcellular accumulation and distribution of the drug inside cells and elucidating the mechanism of action but also differentiating, as a function of time, the subsequent cellular response. It is notable that the nucleolus is the first to be saturated by DOX and it is the first cellular compartment to be affected and to react to this treatment, highlighting the importance of this organelle in cancer development and in cancer therapy.
The profile of spectroscopic responses is complex, being a label-free combinatorial response of the affected biochemcial constituents in each region. Nevertheless, that profile is well defined in terms of subcellular region and temporal evolution, indicating the potential of the technique as an in vitro, preclinical screening technique for drug efficacy and mode of action. Exploring differences in responses could ultimately elucidate meachnisms of cellular resistance, towards applications in companion diagnostics.
